Related Experiment Video
Updated: Mar 24, 2026
Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
Career-Long Earnings in Cardiothoracic Surgery: A Comparative Net Present Value Analysis
Lawrence E Greiten1, Taufiek Konrad Rajab1, Suyog Mokashi2
1Division of Congenital Cardiac Surgery, Department of Surgery, Arkansas Children's Hospital, Little Rock, Arkansas.
Insights
Cardiothoracic surgeons achieve high lifetime earnings, with adult cardiac and congenital heart surgeons earning more than thoracic surgeons. Congenital heart surgery offers the greatest income potential and variability.
Area of Science:
- Medical Economics
- Surgical Compensation Analysis
- Cardiothoracic Surgery
Background:
- Cardiothoracic surgery demands extensive training and offers high financial rewards.
- Long-term financial outcomes across cardiothoracic subspecialties require further clarification.
- This study assesses the lifetime net present value (NPV) of earnings for cardiothoracic surgeons.
Purpose of the Study:
- To evaluate the lifetime net present value (NPV) of earnings for cardiothoracic surgeons.
- To analyze financial implications across different subspecialties (thoracic, adult cardiac, congenital heart).
- To account for variations in training pathways, income percentiles, and career trajectories.
Main Methods:
- Developed a net present value (NPV) model using 2024 salary data.
- Stratified analysis by years of post-training experience and subspecialty.
- Modeled integrated and traditional training pathways, income percentiles, and used Monte Carlo simulation.
Main Results:
- Lifetime NPV estimates: $19.3M (adult cardiac), $19.1M (congenital heart), $14.1M (thoracic) at 50th percentile.
- Thoracic surgeons showed consistently lower earnings.
- Congenital heart surgeons had higher variability and potential for greater later-career compensation, exceeding $40M at the 90th percentile with extended careers.
Conclusions:
- Cardiothoracic surgeons realize substantial lifetime income despite prolonged training.
- Adult cardiac and congenital heart surgeons achieve higher NPVs than thoracic surgeons.
- Congenital heart surgery presents the highest variability and earning potential.
Background:
Cardiothoracic surgery requires prolonged training and offers among the highest compensation in medicine. However, the long-term financial implications across cardiothoracic subspecialties remain incompletely characterized. This study evaluated the lifetime net present value (NPV) of earnings for cardiothoracic surgeons, accounting for variation by subspecialty, training pathway, income percentile, and career trajectory.
Methods:
We developed an NPV model using salary data from the 2024 Society of Thoracic Surgeons Cardiothoracic Surgery Compensation Report, stratified by years of posttraining experience. Integrated and traditional training pathways were modeled for thoracic surgery, adult cardiac surgery, and congenital heart surgery across income percentiles. Scenario analyses evaluated leadership roles, career length, and discount rate sensitivity. A Monte Carlo simulation incorporated uncertainty across key model variables.
Results:
Modeled lifetime NPV ranked among the highest in medicine, with estimates of $19.3 million for adult cardiac surgeons, $19.1 million for congenital heart surgeons, and $14.1 million for thoracic surgeons at the 50th income percentile. Thoracic surgeons demonstrated consistently lower earnings across scenarios. Congenital heart surgeons exhibited greater variability, reflecting delayed entry into the workforce and the potential for substantially higher compensation later in their careers. At the 90th income percentile with prolonged careers and leadership roles, discounted lifetime earnings for congenital heart surgeons exceeded $40 million.
Conclusions:
Despite prolonged training and delayed earnings, cardiothoracic surgeons achieve substantial lifetime income. Thoracic surgeons earn less than their peers, whereas adult cardiac and congenital heart surgeons achieve higher lifetime NPV, with congenital heart surgery exhibiting the greatest variability and potential upside.
